Pityriasis rosea developing after COVID-19 vaccination

J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722. doi: 10.1111/jdv.17498. Epub 2021 Jul 21.

Authors

O Y Marcantonio-Santa Cruz¹, A Vidal-Navarro¹, D Pesqué¹, A M Giménez-Arnau¹, R M Pujol¹, G Martin-Ezquerra¹

Affiliation

¹ Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
Pityriasis Rosea* / etiology
SARS-CoV-2
Vaccination / adverse effects

Substances

COVID-19 Vaccines